Featured Research

from universities, journals, and other organizations

Estrogen Holds Promise As Preventive Therapy For Cardiovascular Disease

Date:
December 6, 2001
Source:
University Of Southern California
Summary:
Taking estrogen appears to reverse thickening in the arteries of healthy, postmenopausal women, according to a study by researchers at the USC Atherosclerosis Research Unit. Atherosclerosis—accumulation of plaque in the arteries—decreased in women using unopposed estrogen therapy in the trial, according to Howard Hodis, M.D., principal investigator and associate professor of medicine and preventive medicine at the Keck School of Medicine of USC.

Taking estrogen appears to reverse thickening in the arteries of healthy, postmenopausal women, according to a study by researchers at the USC Atherosclerosis Research Unit. Atherosclerosis—accumulation of plaque in the arteries—decreased in women using unopposed estrogen therapy in the trial, according to Howard Hodis, M.D., principal investigator and associate professor of medicine and preventive medicine at the Keck School of Medicine of USC. The article appears in the Dec. 4 issue of the Annals of Internal Medicine.

The study is the first randomized controlled trial to test estrogen’s effectiveness in preventing atherosclerosis progression in women with no existing heart trouble. Atherosclerosis is the major contributor to life-threatening events, accounting for more than 1.5 million heart attacks and 600,000 strokes every year in the United States, Hodis says, and is the number one cause of death in women.

Women’s own estrogen helps protect them from cardiovascular disease during youth, but as women pass through menopause, that protection evaporates—and the risk mounts for heart attacks or strokes.

"If you can reduce the progress of atherosclerosis, though, that change translates into a reduced risk for heart attacks or strokes," Hodis says. "The idea is to reach women early in menopause, to prevent those cardiovascular events that commonly occur later."

Called the Estrogen in the Prevention of Atherosclerosis Trial (EPAT) the study monitored how much artery walls thickened over two years in 222 healthy postmenopausal women who took unopposed estrogen or a placebo.

Women on estrogen therapy saw their atherosclerosis rate decrease by .0017 millimeters (mm) per year over two years, while artery wall thickness increased by .0036 mm per year over two years in women who took a placebo.

As a guideline, Hodis says, an increase of .033 mm per year translates to a two-to-three-fold increase in risk of events such as heart attacks, and a starting thickness of .8 mm or greater also puts an individual at high risk.

The EPAT trial is one of a number of studies in postmenopausal women to examine the interaction between hormone replacement therapy and cardiovascular disease. Some recent widely publicized studies showed little benefit in using estrogen, but those studies were done in women with existing cardiovascular disease. EPAT participants were free from heart disease and began the estrogen replacement therapy at a younger age than women in previous trials, Hodis notes.

Also, EPAT investigators could compare women who used cholesterol-lowering drugs against women who did not take such medication. Besides taking estrogen or a placebo, all women who started the trial with levels of 160 or higher of low-density lipoprotein (often called LDL or "bad" cholesterol) were put on a cholesterol-lowering medication.

Among the group of women who took no cholesterol-lowering medications in EPAT, those on estrogen therapy had .0147 mm per year slower atherosclerosis progression than those who took a placebo.

Interestingly, women who received both estrogen and cholesterol-lowering drugs had about the same decrease in atherosclerosis progression as women who took cholesterol-lowering drugs alone.

Researchers do not know why the combination of estrogen and cholesterol-lowering drugs does not result in even further atherosclerosis improvement. "But the effects of lipid-lowering drugs are quite powerful," Hodis says. "You’re probably not seeing any effect above that."

Hodis notes that use of unopposed estrogen generally is restricted to postmenopausal women who have had a hysterectomy. Physicians usually recommend that other postmenopausal women use hormone replacement therapy pairing estrogen with progestin instead, to reduce uterine cancer risk. Women considering the therapies should speak with their physician.

Studies are unclear on whether estrogen-and-progestin hormone therapy offers cardiovascular effects similar to unopposed estrogen. The Atherosclerosis Research Unit recently completed the WELL-HART Study, which tested the effects of such therapy in women with existing heart disease, and researchers plan to examine its effects in healthy women as well.

Scientists have a few ideas about how estrogen deters atherosclerosis in healthy women, but the exact mechanism is unknown. A variety of factors, including the amount and type of fat in the diet, blood cholesterol levels, exercise habits, smoking and heredity, contribute to atherosclerosis progression.

###

Reference: Howard N. Hodis, Wendy J. Mack, Roger A. Lobo, Donna Shoupe, Alex Sevanian, Peter R. Mahrer, Robert H. Selzer, Chao-ran Liu, Ci-hua Liu, and Stanley P. Azen. "Estrogen in the Prevention of Atherosclerosis," Annals of Internal Medicine, Dec. 4, 2001, Vol. 135, No. 11.


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "Estrogen Holds Promise As Preventive Therapy For Cardiovascular Disease." ScienceDaily. ScienceDaily, 6 December 2001. <www.sciencedaily.com/releases/2001/12/011204073135.htm>.
University Of Southern California. (2001, December 6). Estrogen Holds Promise As Preventive Therapy For Cardiovascular Disease. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2001/12/011204073135.htm
University Of Southern California. "Estrogen Holds Promise As Preventive Therapy For Cardiovascular Disease." ScienceDaily. www.sciencedaily.com/releases/2001/12/011204073135.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins